ArticleFrontiers in oncology2021

Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation.

Yongguang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.